Vita Coco | 8-K: FY2025 Q2 Revenue Beats Estimate at USD 168.76 M

Revenue: As of FY2025 Q2, the actual value is USD 168.76 M, beating the estimate of USD 161.56 M.

EPS: As of FY2025 Q2, the actual value is USD 0.38, beating the estimate of USD 0.3543.

EBIT: As of FY2025 Q2, the actual value is USD 28.17 M, beating the estimate of USD 25.75 M.

Segment Revenue

• Net Sales: Increased 17% to $169 million in Q2 2025, driven by a 25% growth in Vita Coco Coconut Water sales.
• Americas Segment: Vita Coco Coconut Water sales were $120.45 million, Private Label $14.685 million, and Other $6.826 million.
• International Segment: Vita Coco Coconut Water sales were $19.882 million, Private Label $6.222 million, and Other $694 thousand.

Operational Metrics

• Net Income: Increased by $4 million to $23 million in Q2 2025.
• Gross Profit: Increased to $61 million from $59 million in the prior year period, with a gross margin of 36% compared to 41%.
• Operating Expenses: Selling, general, and administrative expenses were $36 million, up from $29 million in the prior year period.
• Non-GAAP Adjusted EBITDA: Decreased to $29.2 million from $32.2 million in the prior year period.

Cash Flow

• Operating Cash Flow: Net cash provided by operating activities was $12.01 million for the six months ended June 30, 2025.
• Free Cash Flow: Not explicitly stated, but net cash used in investing activities was - $1.508 million.

Unique Metrics

• Inventory Levels: Remained healthy at $84 million, similar to December 31, 2024 levels.
• Accounts Receivable: Increased to $103 million from $63 million as of December 31, 2024, primarily due to increased net sales.

Outlook / Guidance

• The company expects full-year 2025 net sales to be between $565 million and $580 million, with high teens growth in Vita Coco Coconut Water and benefits from the rollout of Vita Coco Treats.
• Gross margin is expected to be approximately 36%, with higher transportation and finished goods costs, partially offset by pricing increases and a higher mix of branded volumes.
• SG&A expenses are expected to increase by low to mid-single digits compared to 2024, with Adjusted EBITDA projected to be between $86 million and $92 million.